Gyre Therapeutics GYRE
NASDAQ GYRE
$7.00 -0.33 (-4.50%)
At close: Oct 1, 2026 · 4:00 PM EDT

Gyre Therapeutics (GYRE) Revenue (2010 - 2026)

Updated

Gyre Therapeutics (GYRE) posted Revenue of $29.11 million for Q2 2026, down 2.1% from $29.73 million a year earlier but up 29.2% from the prior quarter.

Analysis

Gyre Therapeutics (GYRE) Revenue (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at Gyre Therapeutics was $119.38 million, up 13.5% year-over-year; for FY2025, it was $116.59 million, up 10.2% from FY2024.

  • Annual Revenue shows a five-year compound annual growth rate of 41.0% (FY2020 to FY2025).
  • In prior years, Gyre Therapeutics' Revenue was $105.76 million in FY2024 (-6.8%), $113.45 million in FY2023 (+10.9%), $102.29 million in FY2022 and $7.34 million in FY2021 (-65.0%).
  • Quarterly Revenue has run from a low of $794,000 in Q1 2022 to a high of $101.5 million in Q4 2022 over five years.
  • On a year-over-year basis, Revenue increased in five of the last eight quarters, with growth averaging 4.3%.
  • The strongest year-over-year quarter for Revenue in the past five years was Q3 2021, with growth of 157.4%; the weakest was Q4 2023, with a decline of 73.3%.
  • According to Business Quant data, Revenue for the three prior quarters was $22.52 million (Q1 2026), $37.2 million (Q4 2025) and $30.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.31 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 16.99 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.38 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 7.80 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.33 Bn
10 Gyre Therapeutics 777.23 Mn 579.94 Mn 26.90 Mn 29.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.11 Mn
Mar 31, 2026 22.52 Mn
Dec 31, 2025 37.20 Mn
Sep 30, 2025 30.56 Mn
Jun 30, 2025 29.73 Mn
Mar 31, 2025 22.06 Mn
Dec 31, 2024 27.87 Mn
Sep 30, 2024 25.49 Mn
Jun 30, 2024 25.23 Mn
Mar 31, 2024 27.17 Mn
Dec 31, 2023 27.15 Mn
Sep 30, 2023 32.04 Mn
Jun 30, 2023 29.33 Mn
Mar 31, 2023 24.93 Mn
Dec 31, 2022 101.50 Mn
Mar 31, 2022 794,000.00
Dec 31, 2021 2.44 Mn
Sep 30, 2021 2.30 Mn
Jun 30, 2021 1.13 Mn
Mar 31, 2021 1.47 Mn
API Access

Gyre Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=GYRE&period=max&api_key=YOUR_API_KEY